摘要
目的探讨活血化瘀方治疗慢性肺原性心脏病急性发作期的疗效。方法130例肺原性心脏病住院患者,随机分为单纯西药组(60例)、活血化瘀方中药组(70例),西药组给予常规西药治疗,中药组在常规西药治疗基础上加服活血化瘀方,疗程2~4周。结果中药组显效39例,有效26例,无效5例,总有效率92.9%;西药组显效29例,有效24例,无效13例,总有效率80.3%,两组总有效率比较差异有显著性意义(P<0.05);中药组在改善咳嗽、咳痰、喘促、心悸、紫绀、水肿等主要症状均较西药组为优(P<0.05)。结论在常规西药治疗的基础上加用活血化瘀方对慢性肺心病急性发作期有较好疗效。
Objective To study the clinical effectiveness of“Blood-Activating and Stasis-Resolving Decoction”in the treatment of the acute attack of chronic pulmonary heart disease .MethodsOne hundred thirty cases of chronic pulmonary heart disease which in acute stage were divided into twogroups at random.60 cases were treated by routine western medicines(control group) and another 70 caseswere treated by the Decoction besides the western medicines (treatment group) ,with a course of 2~4weeks. Results The total effective rate was 92.9 % in treatment group and 80.3 % in control group ,and the difference was significantly(P<0.05);the relief of such symptoms as cough ,expectoration ,asthma,palpitation,cyanosis and edema was more obvious in treatment group than in control group(P < 0.05).Conclusion It is better of Blood-Activating and Stasis-Resolving Decoction besides the westernmedicines than simple routine western medicines.
出处
《国际医药卫生导报》
2004年第14期178-180,共3页
International Medicine and Health Guidance News
关键词
活血化瘀方
肺原性心脏病
慢性
急性发作
Blood-Activating and Stasis-Resolving Decoction” Pulmonary heart disease/ chronicAcute stage